Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
95.86
+1.41 (1.49%)
Jan 21, 2026, 2:21 PM EST - Market open
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 15 analysts that cover Inspire Medical Systems stock have a consensus rating of "Buy" and an average price target of $133.07, which forecasts a 38.82% increase in the stock price over the next year. The lowest target is $85 and the highest is $180.
Price Target: $133.07 (+38.82%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 4 | 5 | 5 | 6 | 7 | 7 |
| Hold | 6 | 7 | 8 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 15 | 14 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $160 → $145 | Buy | Maintains | $160 → $145 | +51.26% | Jan 14, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $165 → $120 | Strong Buy | Maintains | $165 → $120 | +25.18% | Jan 8, 2026 |
| UBS | UBS | Hold Maintains $89 → $91 | Hold | Maintains | $89 → $91 | -5.07% | Dec 23, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $125 → $175 | Buy | Maintains | $125 → $175 | +82.56% | Dec 17, 2025 |
| Mizuho | Mizuho | Buy Maintains $110 → $130 | Buy | Maintains | $110 → $130 | +35.61% | Dec 17, 2025 |
Financial Forecast
Revenue This Year
924.46M
from 802.80M
Increased by 15.15%
Revenue Next Year
1.03B
from 924.46M
Increased by 10.98%
EPS This Year
1.06
from 1.75
Decreased by -39.55%
EPS Next Year
1.77
from 1.06
Increased by 67.66%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 957.5M | 1.1B | ||||
| Avg | 924.5M | 1.0B | ||||
| Low | 882.0M | 977.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 19.3% | 20.5% | ||||
| Avg | 15.2% | 11.0% | ||||
| Low | 9.9% | 5.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.73 | 2.43 | ||||
| Avg | 1.06 | 1.77 | ||||
| Low | 0.43 | 1.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.0% | 129.3% | ||||
| Avg | -39.6% | 67.7% | ||||
| Low | -75.4% | 21.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.